๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chemotherapy Effect
Clinical trial register · China

Chemotherapy Effect Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 11 Beijing 3 Hanzhou 2 Nanjing 2 Hangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou11 Beijing3 Hanzhou2 Nanjing2 Hangzhou1
All 8 locations
Target enrolment
to

Chemotherapy Effect trials in China

22 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
NCT07267806Hepato Cellular Carcinoma (HCC), Chemotherapy Effect
Linhui Peng
Phase 3
326
Guangzhou
2025-10-31
Recruiting
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
NCT06510010Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
198
Guangzhou
2024-12-31
Not yet open
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
NCT06567600Intrahepatic Cholangiocarcinoma, Chemotherapy Effect, Immunotherapy
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2
43
Guangzhou
2024-09-01
Recruiting
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
NCT06041477Hepatocellular Carcinoma, Chemotherapy Effect, Chemotherapeutic Toxicity
Sun Yat-sen University
Phase 3
540
Guangzhou
2023-10-31
Recruiting
Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
NCT06043999Chemotherapy Effect, Rectal Cancer
Sun Yat-sen University
Not applicable
392
Guangzhou
2023-09-01
Recruiting
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
NCT05983783Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemotherapy Effect
The First Affiliated Hospital with Nanjing Medical University
Phase 3
200
Nanjing
2023-08-01
Recruiting
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
NCT06172205BCLC Stage C Hepatocellular Carcinoma, Chemotherapy Effect
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
262
Guangzhou
2023-07-01
Recruiting
Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
NCT05797467Colorectal Cancer, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
366
Guangzhou
2023-04-01
Recruiting
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
NCT05212454Breast Cancer, Chemotherapy Effect
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
400
Hanzhou
2023-03-15
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
490
Guangzhou
2023-02-20
Recruiting
Study of Comparing of With and Without Sequential Therapy of S-1
NCT05813015Locally Advanced Gastric Adenocarcinoma, Chemotherapy Effect
Zhejiang University
Phase 3
70
Hanzhou
2023-01-28
Recruiting
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ยฑ Silibinin in Treating Newly Diagnosed AML (Non-M3).
NCT07561892Acute Myeloid Leukemia, Newly Diagnosed, Chemotherapy Effect
Fujian Medical University Union Hospital
Phase 4
100
Fuzhou
2022-04-01
Active, closed
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
NCT05177731AML, Adult, Chemotherapy Effect
Chen Suning
Phase 3
188
Suzhou
2022-03-01
Recruiting
Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
NCT05424692Colon Cancer, Rectal Cancer, Chemotherapy Effect, PTC
Peking Union Medical College Hospital
Not applicable
200
Beijing
2021-09-01
Recruiting
S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma
NCT04989985Locally Advanced Gastroesophageal Junction Adenocarcinoma, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
302
Guangzhou
2021-09-01
Recruiting
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
NCT05775419Esophageal Squamous Cell Carcinoma, Chemotherapy Effect, Side Effect of Drug
The First Affiliated Hospital with Nanjing Medical University
Not applicable
1,216
Nanjing
2021-06-30
Recruiting
Topotecan and Melphalan for Retinoblastoma
NCT04799002Retinoblastoma, Chemotherapy Effect
Sun Yat-sen University
Phase 3
50
Guangzhou
2021-03-11
Recruiting
Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer
NCT04483076Gastric Cancer, Chemotherapy Effect
Chinese PLA General Hospital
Phase 3
524
Beijing
2021-01-13
Recruiting
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect
Hunan Cancer Hospital
Observational
1,000
Changsha
2019-03-01
Recruiting
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
NCT03498326Pancreatic Cancer, Chemotherapy Effect
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
480
Hangzhou
2018-04-02
Recruiting
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
NCT06451393Gastric Cancer, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
500
Guangzhou
2013-02-01
Recruiting
Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT04821843Esophageal Cancer, Chemotherapy Effect, Chemoradiation, Surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
2,000
Beijing
2002-01-01
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/chemotherapy-effect

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies listing the condition Chemotherapy Effect.

How many Chemotherapy Effect trials are recruiting in China?

20 of the 22 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chemotherapy Effect), 22 studies
PhaseStudiesRecruitingShare
Phase 3121154.5%
Phase 24318.2%
Not applicable3313.6%
Observational229.1%
Phase 4114.5%

Most active sponsors

Lead sponsors with the most studies (Chemotherapy Effect)
Lead sponsorStudiesRecruiting
Sixth Affiliated Hospital, Sun Yat-sen University55
Sun Yat-sen University33
Second Affiliated Hospital, Zhejiang University, School of Medicine22
The First Affiliated Hospital with Nanjing Medical University22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Chen Suning10
Chinese PLA General Hospital11
Fujian Medical University Union Hospital11
Hunan Cancer Hospital11
Linhui Peng11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.